|
| Breast aging |
11 |
$2,675,409 |
| Breast development |
16 |
$4,297,303 |
| Breast function |
29 |
$6,339,122 |
| Defining the danger |
7 |
$1,629,736 |
|
| Access to screening |
16 |
$3,471,050 |
| Biomarkers |
32 |
$5,925,985 |
| Imaging technologies |
40 |
$8,220,211 |
|
| Environment |
34 |
$9,432,104 |
| Hormones and nutrition |
25 |
$4,771,753 |
| Other searches |
13 |
$2,339,385 |
|
| Health Policy and Health Services |
27 |
$6,671,274 |
|
| Gene therapy |
37 |
$7,767,750 |
| Hormone and chemotherapy targets |
32 |
$6,091,727 |
| Immune therapy |
32 |
$6,642,505 |
| New drug design |
48 |
$11,786,544 |
|
| Cell growth |
75 |
$12,059,684 |
| Mistakes on the master blueprint |
33 |
$5,318,630 |
| Outbreak |
66 |
$13,449,751 |
| Searching the unknown |
32 |
$6,767,431 |
| Unraveling the path |
50 |
$9,211,511 |
|
| Active lifestyle |
7 |
$1,959,736 |
| Nutritional pathways |
28 |
$11,424,353 |
| Risk reduction |
6 |
$1,300,912 |
|
| Racial/Ethnic Differences |
45 |
$8,281,171 |
|
| Sociocultural, Behavioral, and Psychological Issues |
70 |
$13,536,794 |
